ARTICLE | Product Development
Cephalon's pain sales
August 13, 2007 7:00 AM UTC
Actiq fentanyl sales grew at an average annual rate of 83% from the time Cephalon acquired the drug via its purchase of Anesta in 2000 until it faced generic competition starting last year. This year,...